Guthrie Clinical Research

Sayre, Pennsylvania 18840

1 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Carcinoma, Non-Small-Cell Lung, Cardio-pulmonary Bypass, Coronary Artery Bypass Graft, Diabetes Mellitus, Gastroparesis, Irritable Bowel Syndrome, Lung Cancer, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Small Cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer — Completed
• Diabetic Gastroparesis Study 05 — Stopped early
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 — Stopped early
• Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 — Stopped early
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome — Completed